Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives

Atopic dermatitis (AD) is a chronic inflammatory skin disorder with high prevalence and a complex pathophysiology. This relapsing and remitting skin disorder has many negative consequences on the patient’s quality of life and that of his family. Until now, moderate-to-severe AD treatment was a sympt...

Descripción completa

Detalles Bibliográficos
Autores principales: Niculet, Elena, Bobeica, Carmen, Stefanopol, Ioana Anca, Pelin, Ana Maria, Nechifor, Alexandru, Onisor, Cristian, Tatu, Alin Laurentiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014825/
https://www.ncbi.nlm.nih.gov/pubmed/35444421
http://dx.doi.org/10.2147/TCRM.S338661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014825/
https://www.ncbi.nlm.nih.gov/pubmed/35444421
http://dx.doi.org/10.2147/TCRM.S338661

Ejemplares similares